.png)
.png)
Director
Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Disclosure(s): AstraZeneca: The HJF, in support of the USU IDCRP, was funded to conduct or augment unrelated Phase III Mab and vaccine trials as part of US Govt. COVID19 response
CAPT Timothy Burgess currently serves as Director, Infectious Diseases Clinical Research Program (IDCRP). He has served in a variety of research and clinical capacities over 20 years in Navy Medicine. He established the Immunology Section in the Department of Viral and Rickettsial Diseases at the Naval Medical Research Center (NMRC) in 2001, investigating immunopathogenesis of dengue hemorrhagic fever. He then served overseas at Naval Medical Research Unit #2 in Jakarta, Indonesia, where he headed the Viral Diseases Program, conducting studies on dengue hemorrhagic fever and avian influenza and engaging with partners throughout the Asia-Pacific as well as the USG Interagency. He returned to NMRC to head the Viral and Rickettsial Diseases Department where he oversaw vaccine development and diagnostic R&D efforts. Subsequent assignments included Deputy Director of the IDCRP and Chief of the Infectious Diseases clinical service at Walter Reed National Military Medical Center, Bethesda. In January 2016, returned to USUHS as Director of IDCRP. He holds the collateral duty position as Navy Medicine Specialty Leader for Infectious Diseases. CAPT Burgess holds an appointment as Associate Professor in the Department of Preventive Medicine and Biostatistics at the F. Edward Hebert School of Medicine, Uniformed Services University.